Pneumococcal polysaccharide vaccine uptake in England, 1989–2003, prior to the introduction of a vaccination programme for older adults | Zendy

Karen Noakes | Zendy; Richard Pebody | Zendy; Usha Gungabissoon | Zendy; Julia Stowe | Zendy; Elizabeth Miller | Zendy

Open Access

Pneumococcal polysaccharide vaccine uptake in England, 1989–2003, prior to the introduction of a vaccination programme for older adults

Author(s) -

Karen Noakes,

Richard Pebody,

Usha Gungabissoon,

Julia Stowe,

Elizabeth Miller

Publication year - 2006

Publication title -

journal of public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.916

H-Index - 82

eISSN - 1741-3850

pISSN - 1741-3842

DOI - 10.1093/pubmed/fdl017

Subject(s) - medicine , pneumococcal polysaccharide vaccine , vaccination , medical prescription , licensure , general practice , vaccination policy , immunization , pediatrics , family medicine , demography , streptococcus pneumoniae , pneumococcal disease , immunology , antibiotics , nursing , sociology , pharmacology , biology , antigen , microbiology and biotechnology

Following the licensure of 23-valent pneumococcal polysaccharide vaccine (23vPPV) in 1989, a risk-group-only immunization policy was implemented in 1992 in England. The PPV programme was extended in 2003 to include all individuals 65 years and over. In England, this was phased in over 3 years. To ascertain the performance of the risk group policy in those 65 years of age and over and provide a baseline to estimate the impact of the universal elderly programme.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research